News
RXi gets new cancer vaccine patents RXi reported today that the patents relate to using the vaccine NeuVax with
Herceptin, a drug for women whose tumors produce too much of a protein called HER2. The patents also cover using NeuVax in patients not eligible for
Herceptin treatment.
... read moreFavorable Court Ruling for PDLI Roche is asserting that it does not owe PDL royalties on sales of Avastin,
Herceptin, Lucentis and Xolair manufactured and sold outside the US. Lucentis is co-marketed by Novartis (NVS - Snapshot Report) and Roche. Roche holds the US marketing rights
... read moreDrug Combination Could Block Escape Route for Triple-Negative Breast Cancers “Triple-negative” breast cancers get their name because they lack three biological markers that make other breast cancers vulnerable to drugs such as tamoxifen or
Herceptin. A well-tested class of drugs called EGFR inhibitors has not been effective
... read more
No comments:
Post a Comment